UnitedHealth Stock News

UnitedHealth's earnings were down last quarter, but the company is showing signs of progress. The stock trades at an attractive valuation in relation to the S&P 500.

We reviewed and maintained our UnitedHealth position through its underwriting crisis, recognizing that management's mispricing of annually renewable policies could be corrected through swift action. Our July exit from Novo Nordisk demonstrates our willingness to move on from positions when competitive dynamics deteriorate. We made several strategic additions during market weakness including Fas...

Skyrizi and Rinvoq sales are pushing AbbVie's sales higher. UnitedHealth Group raised its full-year guidance and is rebounding from a disastrous 2025.

--(BUSINESS WIRE)--UNH Board Authorizes Payment of Quarterly Dividend.

UnitedHealth Group (UNH) remains bullish, supported by strong EPS guidance, cost-cutting via AI, and premium increases well below sector averages. UNH's strategy to absorb cost pressures instead of passing them to members preserves membership and drives double-digit revenue growth despite sector headwinds. Optum AI and proactive provider negotiations position UNH for margin improvement and cont...

UnitedHealth (UNH) shares have dropped 10% over the last week and are presently trading at $330.83. We believe there are only a few aspects to be wary of in UNH stock, considering its overall Moderate operating performance and financial health.

Top investors Michael Burry and Warren Buffett aren't known for following the crowd. This independence has scored wins for them and their clients over time.

UnitedHealth Group is showing solid signs of stabilization after July's capitulation, with Berkshire's investment boosting sentiments and a resilient Q3 performance lending a calming influence. UNH's medical cost ratio improvement and double-digit earnings growth expected by 2027 underpin a positive long-term outlook, despite current margin pressures. Valuation has rebounded near its 10-year av...